These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1928816)

  • 21. [Biorheological views of diabetic macroangiopathy].
    Uchimura I
    Nihon Rinsho; 2006 Nov; 64(11):2159-63. PubMed ID: 17087312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ticlopidine: a new platelet aggregation inhibitor.
    Ito MK; Smith AR; Lee ML
    Clin Pharm; 1992 Jul; 11(7):603-17. PubMed ID: 1617911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemorheological improvement after Daflon 500 mg treatment in diabetes.
    Lacombe C; Bucherer C; Lelievre JC
    Int Angiol; 1988; 7(2 Suppl):21-4. PubMed ID: 3183453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
    Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
    Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of naftidrofuryl, a serotonergic antagonist, on erythrocyte aggregation.
    Nordt FJ; Jack W; Coull BM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S29-32. PubMed ID: 1369714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum protein media are important factors in the manual hexadimethrine bromide (polybrene) test, experience in China.
    Liu F; Hu LH
    Transfus Clin Biol; 2005 Feb; 12(1):34-7. PubMed ID: 15814291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.
    Vayá A; Falcó C; Réganon E; Vila V; Martínez-Sales V; Corella D; Contreras MT; Aznar J
    Thromb Haemost; 2004 Feb; 91(2):354-9. PubMed ID: 14961164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of different antimigraine compounds on platelet and erythrocyte aggregation.
    Evers S; Heuel T; Frese A; Akova-Oztürk E; Husstedt IW
    Cephalalgia; 2006 Aug; 26(8):920-4. PubMed ID: 16886927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial.
    Knudsen JB; Kjøller E; Skagen K; Gormsen J
    Thromb Haemost; 1985 Jun; 53(3):332-6. PubMed ID: 3901391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregation behaviour in patients treated with ticlopidine.
    Petronio AS; Evangelisti L; Preti R; Gherarducci G; Balbarini A; Giordani R; Mariani M
    Drugs Exp Clin Res; 1987; 13(1):43-50. PubMed ID: 3595443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Is ticlopidine hydrochloride preferred in prevention of thrombotic cerebral infarct over acetylsalicylic acid?].
    Kunze K
    Internist (Berl); 1994 Sep; 35(9):882. PubMed ID: 7960573
    [No Abstract]   [Full Text] [Related]  

  • 33. Diabetic microangiopathic hemolytic anemia: beneficial effect of an antiplatelet agent?
    Dupont AG; Van der Niepen P; Sennesael J; Somers G
    Diabetes Care; 1985; 8(2):169-71. PubMed ID: 3996174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aspirin vs ticlid and their combination in patients with acute myocardial infarction].
    Vyshlov EV; Panfilova EV; Markov VA
    Klin Med (Mosk); 2000; 78(1):37-9. PubMed ID: 10697373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antiplatelet therapy in patients with cerebral thrombosis at the chronic phase--assessment of its effect on coagulation and fibrinolytic parameters].
    Kohriyama T; Tanaka E; Katayama S; Yamamura Y; Nakamura S
    Rinsho Shinkeigaku; 1994 Aug; 34(8):771-6. PubMed ID: 7994982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
    Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
    Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus.
    Fatima N; Pingali U; Muralidhar N
    Phytomedicine; 2014 Apr; 21(5):579-85. PubMed ID: 24291054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
    Barras JP; Michal M
    Vasa; 1986; 15(3):200-5. PubMed ID: 3532608
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanism of action and clinical use of ticlopidine].
    Kirichenko AA
    Kardiologiia; 2006; 46(4):75-80. PubMed ID: 16710210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patients with acute coronary syndromes.
    Storey RF; Husted S; Harrington RA; Heptinstall S; Wilcox RG; Peters G; Wickens M; Emanuelsson H; Gurbel P; Grande P; Cannon CP
    J Am Coll Cardiol; 2007 Nov; 50(19):1852-6. PubMed ID: 17980251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.